CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-β signaling

Oncogene

Volumn 27, Issue 5, 2008, Pages 675-683

  Han, S U ^a,e   Kwak, T H ^a   Her, K H ^a,f   Cho, Y H ^a,g   Choi, C ^a   Lee, H J ^a,b   Hong, S ^a   Park, Y S ^a   Kim, Y S ^c   Kim, T A ^a   Kim, S J ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Hanyang University   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e Ajou University School of Medicine   (South Korea)

^f Jeju National University School of Medicine   (South Korea)

^g Konkuk University Hospital   (South Korea)

Author keywords

Carcinoembryonic antigen; Gastric cancer; Smad3; TGF

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN CEACAM5; CARCINOEMBRYONIC ANTIGEN CEACAM6; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CEACAM5 GENE; CEACAM6 GENE; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH EPITHELIUM;

ANIMALS; ANTIGENS, CD; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CELL LINE, TUMOR; HUMANS; MICE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 38549143104     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210686     Document Type: Article

References (33)

1. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. (1989). Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327-334.
2. Bessa X, Elizalde JI, Mitjans F, Pinol V, Miquel R, Panes J et al. (2002). Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor β1. Gastroenterology 122: 1122-1132.
3. Chakrabarty S, Tobon A, Varani J, Brattain MG. (1998). Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-β. Cancer Res 48: 4059-4064.
4. Chang J, Park K, Bang YJ, Kim WS, Kim D, Kim SJ. (1997). Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res 57: 2856-2859.
5. Chevinsky AH. (1991). CEA in tumors of other than colorectal origin. Semin Surg Oncol 7: 162-166.
6. Ergun S, Kilik N, Ziegeler G, Hansen A, Nollau P, Götze J et al. (2000). CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 5: 311-320.
7. Feng XH, Liang YY, Liang M, Zhai W, Lin X. (2002). Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). Mol Cell 9: 133-143.
8. Gold P, Freedman SO. (1965). Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467-481.
9. Hammarström S. (1999). The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9: 67-81.
10. Han SU, Kim HT, Seong DH, Kim YS, Park YS, Bang Y-J et al. (2004). Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 23: 1333-1341.
11. Heldin CH, Miyazono K, ten Dijke P. (1997). TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
12. Huang J, Hardy JD, Sun Y, Shively JE. (1999). Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. J Cell Sci 112: 4193-4205.
13. Ignotz RA, Massague J. (1987). Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell 51: 189-197.
14. Ilantzis C, DeMarte L, Screaton RA, Stanners CP. (2002). Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 4: 151-163.
15. Kammerer R, Hahn S, Singer BB, Luo JS, von Kleist S. (1998). Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur J Immunol 28: 3664-3674.
16. Kammerer R, Stober D, Singer BB, brink B, Reimann J. (2001). Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation. J Immunol 166: 6537-6544.
17. Kammerer R, von Kleist S. (1994). The carcinoembryonic antigen (CEA) modulates effector-target cell interaction by binding to activated lymphocytes. Int J Cancer 57: 341-347.
18. Kang SH, Bang YJ, Jong HS, Seo JY, Kim KN, Kim S-J. (1999). Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells. Br J Cancer 80: 1144-1149.
19. Kim DY, Kim HR, Shim JH, Park CS, Kim SK, Kim YJ. (2000). Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. J Surg Oncol 74: 185-192.
20. Kim J, Kaye FJ, Henslee JG, Shively JE, Park JG, Lai SL et al. (1992). Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. Int J Cancer 52: 718-725.
21. Kim S-J, Im Y-H, Markowitz SD, Bang Y-J. (2000). Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev 11: 159-168.
22. Kuijpers TW, Hoogerwerf M, van der Laan LJ, Nagel G, van der Schoot CE, Grunert F et al. (1992). CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J Cell Biol 118: 457-466.
23. Massague J, Chen YG. (2000). Controlling TGF-β signaling. Genes Dev 14: 627-644.
24. Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K et al. (1995). A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547.
25. Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C. (1993). Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA 90: 10744-10748.
26. Ordonez C, Screaton RA, Ilantzis C, Stanners CP. (2000). Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 60: 3419-3424.
27. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH et al. (1997). Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70: 443-449.
28. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB et al. (1994). Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772-8776.
29. Screaton RA, DeMarte L, Draber P, Stanners CP. (2000). The specificity for the differentiation blocking activity of carcinoembryonic antigen resides in its glycophosphatidyl-inositol anchor. J Cell Biol 150: 613-626.
30. Wakefield LM, Roberts AB. (2002). TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
31. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H et al. (1999). Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 18: 1280-1291.
32. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B et al. (1998). Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611-617.
33. Zimmermann W. (1998). The nature and expression of the rodent CEA families: evolutionary considerations. In: Stanners CP (ed). Cell Adhesion and Communication Mediated by the CEA Family. Harwood Academic Publishers: Amsterdam, The Netherlands. pp 31-55.